Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Amicus Therapeutics (FOLD) Long-Term Debt Issuances (2016 - 2018)

Amicus Therapeutics' Long-Term Debt Issuances history spans 6 years, with the latest figure at -$26000.0 for Q4 2018.

  • For the quarter ending Q4 2018, Long-Term Debt Issuances changed N/A year-over-year to -$26000.0, compared with a TTM value of -$26000.0 through Dec 2021, changed 0.0%, and an annual FY2023 reading of $387.4 million, changed N/A over the prior year.
  • Long-Term Debt Issuances for Q4 2018 was -$26000.0 at Amicus Therapeutics, down from $243.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $243.0 million in Q4 2016, with the low at -$26000.0 in Q4 2018.
  • Average Long-Term Debt Issuances over 3 years is $82.7 million, with a median of $5.0 million recorded in 2014.
  • Biggest YoY gain for Long-Term Debt Issuances was 0.0% in 2014; the steepest drop was 0.0% in 2014.
  • Tracing FOLD's Long-Term Debt Issuances over 3 years: stood at $5.0 million in 2014, then soared by 4760.0% to $243.0 million in 2016, then crashed by 100.01% to -$26000.0 in 2018.
  • Per Business Quant, the three most recent readings for FOLD's Long-Term Debt Issuances are -$26000.0 (Q4 2018), $243.0 million (Q4 2016), and $5.0 million (Q1 2014).